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An Assessment of Clinical Wound Evaluation Scales 
JAMES V. QUINN, MD, GEORGE A. WELLS, MD 
Abstract. Objective: To compare 2 clinical wound 
scales and to determine a minimal clinically impor- 
tant difference (MCID) on the visual analog cosmesis 
scale. Methods: Using data from 2 previously pub- 
lished clinical trials, 91 lacerations and 43 surgical 
incisions were assessed on the 2 scales; a 100-mm 
visual analog scale (VAS) (0 = worst possible scar, 100 
= best possible scar) and a wound evaluation scale 
(WES) assessing 6 clinical variables (a score of 6 is 
considered optimal, while a score of 5 5  suboptimal). 
All wound assessments on the VAS were done by 2 
cosmetic surgeons who rated photographs on 2 occa- 
sions. A cohort of wounds on the WES were assessed 
by a second observer. The difference of the mean op- 
timal and suboptimal VAS scores for each study was 
used to determine a MCID on the VAS scale. Results: 
The VAS scale yielded intraobserver agreements of 
0.93 and 0.87 (95% CI: 0.89-0.96 and 0.78-0.93) and 
interobserver agreements of 0.50 and 0.71 (95% CI: 
0.32-0.65 and 0.52-0.84) for lacerations and inci- 
sions, respectively. Kappa coefficient measuring 
agreement on the WES was 0.79 (95% CI: 0.57-1.0). 
The mean (?SD) VAS scores of optimal wounds were 
72 5 12 mm and 65 5 20 mm, while the mean scores 
of suboptimal wounds were 57 ? 17 mm and 50 2 23 
mm for lacerations and incisions, respectively. Con- 
clusions: An MCID on the VAS cosmesis scale is 15 
mm. Studies should be designed to have a sample size 
and power to detect this difference. Key words: 
wounds; lacerations; tissue adhesives; sutures; sta- 
ples; infection; cosmetic appearance. ACADEMIC 
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ALJD, reliable outcome measures that can V assess important clinical differences are es- 
sential tools for clinical trials.' Investigators have 
been interested in measuring important but sub- 
jective outcomes for some time. Outcome measures 
have been developed to evaluate subjective out- 
comes such as quality of life, and ~ a i n . ~ . ~  Recently 
there has been interest in clinical wound healing, 
and several scales have been developed to measure 
the cosmetic outcomes of healed lacerations and in- 
cisions.4~6 A visual analog cosmesis scale, like the 
visual analog pain scale, has become a desirable 
method of clinical evaluation because of its contin- 
uous nature, ability to measure small differences, 
reproducible results, and ease of use. 
The difficulty with visual analog scales (VASs) 
is that although they can measure small changes 
and statistical differences between groups, the 
clinical relevance of the numerical results and im- 
portant clinical differences on these scales are not 
i n t ~ i t i v e . ~ . ~  To improve the VAS scale as an out- 
come measure, the determination of minimal clin- 
ical important differences (MCIDs) is essential to 
their proper use. In addition, they should be com- 
bined with descriptive scales that can better define 
the numerical results of the VAS. To date, inves- 
tigators have determined this MCID on VAS pain 
scales' and the VAS cosmesis scale has been com- 
bined and contrasted with descriptive  scale^.^ This 
is the first study to  derive an MCID for the VAS 
cosmesis scale. 
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METHODS 
Studg Design. We performed a retrospective 
analysis and comparison of 2 scales used to mea- 
sure the cosmetic outcomes of healed lacerations 
and incisions of 2 previously published studies. Ap- 
proval to  analyze the data from published studies 
using these scales was granted from the institu- 
tional review board at the University of Michigan. 
Population and Settings. The data from 2 pro- 
spective trials on laceration treatment8 and surgi- 
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TABLE 1. Wound Evaluation Scale* 
1. Stepoff borders (0 for yes, 1 for no) 
2. Contour irregularity-puckering 
3. Scar width-greater than 2 mm 
4. Edge inversion-sinking, curling 
5. Inflammation-redness, discharge 
6. Overall cosmesis (0  = poor, 1 = acceptable) 
*6/6 = optimal wound healing. 
cyanoacrylate tissue adhesive. All wounds in this 
study had identical closures of the deep layer prior 
to skin closure. The average length of the incisions 
was 9.4 cm. The same 2 methods of wound evalu- 
ation (WES and VAS) were used, but were per- 
formed at 1 month rather than 3 months for the 
laceration study. 
Data Analysis. The mean 2 SD of the VAS cos- 
mesis scores for optimal and suboptimal wounds 
was determined for each study The MCID on the 
VAS was considered to be the distance between an 
average optimal Score and an average suboptimal 
score. Observer agreement of the cosmetic SUr- 
geons on their VAS scores was determined using 
the intraclass correlation coefficient. Agreement on 
the WES was determined using the kappa (K) co- 
cal incisions treatment were used. The trials corn- 
pared traditional suturing with the use of a new 
topical tissue adhesive. The laceration study in- 
cluded all facial lacerations as well as certain se- 
lected extremity and torso lacerations. The surgi- 
cal incision study compared incisions from a wide 
variety of head and neck incisions. 
Measurements. In the laceration study, patients 
were prospectively randomized to have the skin of 
their lacerations closed with either 5-0 monofila- 
ment suture or topical tissue adhesive. The aver- 
age length of laceration in the study was 2.5 cm, 
and 12.5% of the lacerations required deep su- 
tures. At 3 months the patients had a wound as- 
sessment done on a previously validated wound 
evaluation scale (WESh4 The score was assigned 
by a research nurse aware of the method of closure 
and validated by a second nurse blinded to the 
method of closure and unaware of previous wound 
scores. Nurses and physicians have been shown to 
use the WES re l iab l~ .~  The wound score addresses 
6 clinical variables: absence of stepoff, contour ir- 
regularities, wound margin separation >2 mm, 
edge inversion, excessive distortion, and overall 
cosmetic appearance. Each of these categories is 
graded on a O-or-l-point scale. A total cosmetic 
score is derived by the addition of the scores of the 
6 categorical variables. A score of 6 is considered 
optimal, while a score of 5 5  suboptimal (Table 1). 
At the same time the WES was determined, the 
patients had photographs of their healing wounds 
taken. The photographs were taken by the re- 
search assistant in a standard fashion using a 1:3 
macro setting with a ring flash and using 100 Ek- 
tachrome slide film.1° These photographs were 
rated for cosmesis on a previously validated cos- 
mesis scale. This VAS for cosmesis has been dem- 
onstrated to be reliable and valid.s The VAS cos- 
mesis scale is a 100-mm line with “worst scar” at 
the right end (0 mm) and “best scar” at the left end 
(100 mm) (Figs. 1 and 2). The photographs were 
rated on 2 occasions by 2 cosmetic surgeons 
blinded to which method was used to close the 
wounds. 
The surgical incision study was a prospective, 
nonrandomized comparison study comparing the 
skin closures of various head and neck incisions 
with either 4-0 nylon subcuticular suture or octyl- 
efficient. Confidence interval estimates for the 
agreement coefficients were calculated. 
RESULTS 
There were 91 patients in the laceration group, 67 
with optimal scores and 24 with suboptimal scores. 
In the incision study, there were 43 patients, 23 
with optimal and 20 with suboptimal wound 
scores. The mean difference in VAS cosmesis scores 
in both the laceration and incision studies was 15 
mm (Figs. 1 and 2). The VAS scale yielded intraob- 
server agreements of 0.93 and 0.87 (95% CI: 
0.89-0.96 and 0.78-0.93) and interobserver agree- 
ments of 0.50 and 0.71 (95% CI: 0.32-0.65 and 
0.52-0.84) for lacerations and incisions, respec- 
tively. The K coefficient measuring agreement on 
the WES was 0.79 (95% CI: 0.57-1.0). 
DISCUSSION 
Until recently most treatments for wounds were 
evaluated and reported as case series.ll Objective 
comparison of treatments with a randomized trial 
was impossible because of the lack of valid, relia- 
ble, and clinically important outcome measures 
that could be assessed in a blinded fashion. Valid 
reliable scales such as the VAS cosmesis scale and 
the WES now make it possible to do this. Any good 
outcome measure should have 5 properties: it 
should measure an important outcome of the in- 
tervention, it should be reliable (i.e., the results 
should be reproducible), it should be valid (i.e., be 
a true measure of the outcome), one should be able 
to measure or determine clinically important dif- 
ferences on the scale, and it should be easy to use 
and understand. 
Several years ago we chose cosmesis as our out- 
come measure for clinical wound evaluation. We 
determined that it was the most important out- 
come for patients by informally surveying 75 pa- 
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tients and parents of children with lacerations. 
While outcomes such as pain and time were very 
important, final cosmetic outcome (80% of the 
time) was the most important outcome to this 
group of surveyed parents and patients with facial 
lacerations. When considering other parts of the 
body i t  was still important (39% of the time), but 
time spent waiting was considered more important 
for these wounds (46%), while pain was third (15%) 
(unpublished data, 1991). Other important out- 
comes such as infection and dehiscence were con- 
sidered, but using them as a primary outcome 
measure is difficult because they are relatively 
rare, and measuring them is problematic because 
many cannot agree on what truly is an  infec- 
tion.12J3 We also believe that important infections 
and dehiscences will manifest themselves as poor 
cosmetic outcomes. 
As noted above, a good outcome measure must 
be reliable, i.e., reproducible. We have shown that 
if a cosmetic surgeon likes the scar the first time 
it is shown to him or her, and then the scar is 
shown to the same surgeon again some time later 
when he or she is unaware of the previous result, 
he or she will give the scar a very similar score 
(intraobserver reliability or agreement). Having 2 
cosmetic surgeons agreeing on the score of the 
wound (interobserver agreement) not only gives it 
a measure of reliability, but also gives it a measure 
of validity. Not surprisingly, agreement of a sur- 
geon with his or her own previous scores tends to 
be stronger than agreement between surgeons, 
and in this study one measurement was only 0.5, 
which is the lower acceptable boundary for such 
agreement.’ However, when analyzing the inci- 
sions in this study, the interobserver ageement 
was 0.71, which was more consistent with previous 
studies where the interobserver agreement consis- 
tently ranges from 0.71 to 0.75.6J4.15 
There is no criterion standard with which to 
measure and test the validity of the VAS cosmesis 
scale. For that reason we believe it is important to 
help define the scale with descriptive measures or 
outcomes that can help to define numerical values 
of the scale and improve its validity. In these 2 
studies we chose to combine it with the WES, 
which assesses various clinical variables when de- 
termining an optimal vs a suboptimal scar. In the 
past we combined the VAS cosmesis scale with a 
descriptive scale that classified wounds into 3 cat- 
egories: excellent, acceptable, and poor, based on 
clinical des~riptors .~ The importance of this is il- 
lustrated in the following example. If one were told 
that the average VAS cosmesis score of a group of 
traumatic lacerations was 68 mm, he or she would 
really have no idea what that  means. I t  may be 
possible to compare them with another group, but 
was the score from this group actually good or bad? 
By knowing that the average optimal score of all 
traumatic wounds was 72 mm, one can be fairly 
confident that  the outcomes in that group are good. 
In another attempt to improve validity, we chose 
to use cosmetic surgeons to evaluate the scars, be- 
cause they are the ones who deal with scars on a 
daily basis and make decisions regarding revision. 
Doing so gives the VAS cosmesis scale a measure 
of “face validity.” 
LIMITATIONS AND FUTURE QUESTIONS 
This study is limited by its retrospective analysis 
of data from 2 studies, which, aside from using the 
same outcome measures, were very different in de- 
sign. The study on lacerations was a prospective, 
randomized trial of traumatic lacerations, on a va- 
riety of sites of the body closed by 10 different phy- 
sicians, with a 3-month blinded cosmetic evalua- 
tion. The study on incisions was a nonrandomized, 
prospective comparison of surgical incisions treated 
by 2 surgeons (1 sutured and 1 applied tissue ad- 
hesive) with a 1-month blinded cosmetic evalua- 
tion. To deal with this limitation we did not at- 
tempt to combine the data of these studies when 
doing our analysis. However, the fact that  both 
scales are reliable and produce similar MCIDs de- 
spite vastly different clinical scenarios leads us to 
I I 
0 VAS Cosmesis Scale 100 
worst rn Optimal best 
scar Suboptimal scar 
Figure 1. Average optimal and suboptimal scores for the 
laceration study. VAS = visual analog scale. 
0 VAS Cosmesis Scale 100 
worst Optimal best 
scar Suboptimal scar 
Fiaure 2. Average optimal and suboptimal scores for the 
incision study. VAS = visual analog scale. 
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believe that our conclusions can be generalized to 
most clinical settings. 
We also assumed that an important clinical dif- 
ference corresponded to  the difference between an 
optimal and a suboptimal W S  score. The assump- 
tion that a scar is clinically less desirable because 
it fails to score on all 6 clinical variables may be 
debated, although the majority of wounds score ei- 
ther a 4-516 (suboptimal) or 6/6 (optimal). Only 
the occasional wound scores less than 4/6. 
Finally, it can be argued that the satisfaction of 
patients with regard to  assessment of their own 
wounds is the most important outcome. Although 
we have considered the MCID that physicians are 
willing to  accept, we have not addressed the MCID 
that patients are willing to accept. Singer et al. 
have shown good concordance between physician 
and patient assessments of wounds.l6 However, us- 
ing patients to assess their wounds has methodo- 
logic problems. It is impossible to  blind patients to 
the treatment of their wounds and when patients 
are not blinded, they are more likely to  bias their 
assessments to please the investigators (Haw- 
thorne effect).17 The VAS used by patients, unlike 
the VAS cosmesis scale, has not yet been validated 
as an outcome measure. Prospective, randomized 
trials using blinded validated outcome measures 
should be the design of choice for clinical wound 
studies, and future rigorously designed studies 
should similarly evaluate patient assessment of 
cosmesis. 
CONCLUSION 
The MCID on the VAS cosmesis 
Studies should be designed with 
have the power to determine this 
scale is 15 mm. 
a sample size to  
difference. Stud- 
ies that have a large sample size may have the 
power to determine statistical differences less than 
this, but the clinical relevance of such smaller dif- 
ferences is uncertain. 
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